China Golden Classic Group Limited (8281.HK)
HKD 0.11
(10.0%)
HKD 0.11
(10.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 84.88 Million CNY | -18.34% |
| 2022 | 103.94 Million CNY | -1.0% |
| 2021 | 105 Million CNY | -15.05% |
| 2020 | 123.6 Million CNY | -22.07% |
| 2019 | 158.6 Million CNY | 1.73% |
| 2018 | 155.9 Million CNY | 12.72% |
| 2017 | 138.3 Million CNY | 7.49% |
| 2016 | 128.66 Million CNY | -3.36% |
| 2015 | 133.14 Million CNY | -1.09% |
| 2014 | 134.6 Million CNY | 31.99% |
| 2013 | 101.97 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 51.26 Million CNY | 0.0% |
| 2024 Q1 | 51.26 Million CNY | -39.6% |
| 2023 Q2 | 75.39 Million CNY | 0.0% |
| 2023 Q4 | 84.88 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 FY | 84.88 Million CNY | -18.34% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q4 | 103.94 Million CNY | 0.0% |
| 2022 Q2 | 61.22 Million CNY | 0.0% |
| 2022 FY | 103.94 Million CNY | -1.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 FY | 105 Million CNY | -15.05% |
| 2021 Q2 | 90.66 Million CNY | 0.0% |
| 2021 Q4 | 105 Million CNY | 0.0% |
| 2020 Q2 | 138.15 Million CNY | 0.0% |
| 2020 Q4 | 123.6 Million CNY | 0.0% |
| 2020 FY | 123.6 Million CNY | -22.07% |
| 2019 Q2 | 143.11 Million CNY | 0.0% |
| 2019 FY | 158.6 Million CNY | 1.73% |
| 2019 Q4 | 158.6 Million CNY | 0.0% |
| 2018 Q4 | 155.9 Million CNY | 0.0% |
| 2018 FY | 155.9 Million CNY | 12.72% |
| 2018 Q2 | 96.56 Million CNY | 0.0% |
| 2017 FY | 138.3 Million CNY | 7.49% |
| 2017 Q2 | 99.37 Million CNY | 0.0% |
| 2017 Q4 | 138.3 Million CNY | 0.0% |
| 2016 FY | 128.66 Million CNY | -3.36% |
| 2016 Q2 | 135.46 Million CNY | 0.0% |
| 2016 Q4 | 128.66 Million CNY | 0.0% |
| 2015 Q4 | 133.14 Million CNY | 0.0% |
| 2015 FY | 133.14 Million CNY | -1.09% |
| 2014 FY | 134.6 Million CNY | 31.99% |
| 2013 FY | 101.97 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 72.447% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 92.019% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | 22.2% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | 52.074% |
| Huasheng International Holding Limited | 675.58 Million HKD | 87.436% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -37.337% |
| Evergreen Products Group Limited | 786.46 Million HKD | 89.207% |
| EC Healthcare | 2.97 Billion HKD | 97.142% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 89.005% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 94.753% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | 50.728% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -98.093% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | 53.194% |